Why we should care about ultra-rare disease

Orphan drugs for patients with ultra-rare diseases: between cost-effectiveness and equality of access to cure http://ow.ly/Zlmf4

Detalles Bibliográficos
Autor principal: Harari, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487247/
https://www.ncbi.nlm.nih.gov/pubmed/27246584
http://dx.doi.org/10.1183/16000617.0017-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487247/
https://www.ncbi.nlm.nih.gov/pubmed/27246584
http://dx.doi.org/10.1183/16000617.0017-2016

Ejemplares similares